IOLCP — IOL Chemicals and Pharmaceuticals Cashflow Statement
0.000.00%
- IN₹19.23bn
- IN₹18.92bn
- IN₹21.33bn
- 94
- 46
- 49
- 72
Annual cashflow statement for IOL Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5,332 | 5,714 | 2,249 | 1,887 | 1,817 |
Depreciation | |||||
Non-Cash Items | 159 | -118 | -101 | -17.5 | -27.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,138 | -2,188 | -1,650 | -1,108 | 483 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4,711 | 3,798 | 931 | 1,223 | 2,901 |
Capital Expenditures | -803 | -1,082 | -1,533 | -2,118 | -2,742 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1,042 | -2,090 | 331 | 918 | 829 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,845 | -3,173 | -1,202 | -1,200 | -1,913 |
Financing Cash Flow Items | -217 | -57 | -81.1 | -164 | -161 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2,719 | -583 | -16.4 | -41.1 | -925 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 147 | 42.5 | -288 | -18.4 | 63 |